These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10747038)

  • 1. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
    Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
    EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
    Berry SE; Loh T; Yan T; Kinsella TJ
    Cancer Res; 2003 Sep; 63(17):5490-5. PubMed ID: 14500385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
    Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
    Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
    Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
    Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
    Christmann M; Kaina B
    J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
    Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
    Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA loop repair by human cell extracts.
    Umar A; Boyer JC; Kunkel TA
    Science; 1994 Nov; 266(5186):814-6. PubMed ID: 7973637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mlh1 can function in antibody class switch recombination independently of Msh2.
    Schrader CE; Vardo J; Stavnezer J
    J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling mismatch repair in cancer.
    Fishel R
    Nat Med; 1999 Nov; 5(11):1239-41. PubMed ID: 10545986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
    Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
    Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
    Leadon SA; Avrutskaya AV
    Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DNA mismatch repair in platinum drug resistance.
    Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
    Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of yeast pms1, msh2, and mlh1 mutators points to differences in mismatch correction efficiencies between prokaryotic and eukaryotic cells.
    Yang Y; Karthikeyan R; Mack SE; Vonarx EJ; Kunz BA
    Mol Gen Genet; 1999 Jun; 261(4-5):777-87. PubMed ID: 10394915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
    Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
    Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DNA mismatch repair genes in naevi.
    Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
    In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
    Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
    Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
    Genschel J; Littman SJ; Drummond JT; Modrich P
    J Biol Chem; 1998 Jul; 273(31):19895-901. PubMed ID: 9677427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.